Filings For: Allogene Therapeutics, Inc.
WHO USES CALCBENCH?    Equity Analysts    Corparate Finance & Reporting    Auditors    Academics

GO TO: Recent Comment Letters


Today


ALL   |    All 10-K/Qs   Large   Mid    Small    Micro    |     Earnings Release    Proxy    |   SORT BY :   Most Recent    Company Name 
CompanyTimeSizeViewFinancialsDocumentSECPeriodRevenue MRQAssetsEPS Diluted
Allogene Therapeutics, Inc. (ALLO) 11/6/2026 6:15:34 AM Small View Financials 10-Q SEC 3Q 2026 ending: 9/30/2026 Assets $511,320,000 EPS -$0.15
Allogene Therapeutics, Inc. (ALLO) 11/5/2026 4:16:00 PM   View Financials Earnings SEC 3Q 2026 Rev $0 Assets $511,320,000 EPS -$0.15 Export Earnings Model
Allogene Therapeutics, Inc. (ALLO) 8/12/2026 4:38:25 PM Small View Financials 10-Q SEC 2Q 2026 ending: 6/30/2026 Rev: $4,640,000 Assets $550,091,000 EPS -$0.13
Allogene Therapeutics, Inc. (ALLO) 8/12/2026 4:13:26 PM   View Financials Earnings SEC 2Q 2026 Rev $4,640,000 Assets $550,091,000 EPS -$0.13 Export Earnings Model
Allogene Therapeutics, Inc. (ALLO) 5/13/2026 4:16:28 PM Small View Financials 10-Q SEC 1Q 2026 ending: 3/31/2026 Assets $395,958,000 EPS -$0.18
Allogene Therapeutics, Inc. (ALLO) 5/13/2026 4:05:05 PM   View Financials Earnings SEC 1Q 2026 Assets $395,958,000 EPS -$0.18 Export Earnings Model
Allogene Therapeutics, Inc. (ALLO) 4/30/2026 6:41:13 PM   View Proxy SEC Y 2025
Allogene Therapeutics, Inc. (ALLO) 3/12/2026 4:24:52 PM Small View Financials 10-K SEC Y 2025 ending: 12/31/2025 Assets $415,905,000 EPS -$0.87
Allogene Therapeutics, Inc. (ALLO) 3/12/2026 4:08:07 PM   View Financials Earnings SEC Y 2025 Rev $0 Assets $415,905,000 EPS -$0.17 Export Earnings Model
Allogene Therapeutics, Inc. (ALLO) 11/6/2025 4:45:30 PM Small View Financials 10-Q SEC 3Q 2025 ending: 9/30/2025 Assets $439,771,000 EPS -$0.19
Allogene Therapeutics, Inc. (ALLO) 11/6/2025 4:33:56 PM   View Financials Earnings SEC 3Q 2025 Rev $0 Assets $439,771,000 EPS -$0.19 Export Earnings Model
Allogene Therapeutics, Inc. (ALLO) 8/13/2025 4:24:35 PM Small View Financials 10-Q SEC 2Q 2025 ending: 6/30/2025 Assets $470,593,000 EPS -$0.23
Allogene Therapeutics, Inc. (ALLO) 8/13/2025 4:12:35 PM   View Financials Earnings SEC 2Q 2025 Rev $0 Assets $470,593,000 EPS -$0.23 Export Earnings Model
Allogene Therapeutics, Inc. (ALLO) 5/13/2025 4:13:50 PM Small View Financials 10-Q SEC 1Q 2025 ending: 3/31/2025 Assets $507,982,000 EPS -$0.28
Allogene Therapeutics, Inc. (ALLO) 5/13/2025 4:08:35 PM   View Financials Earnings SEC 1Q 2025 Rev $0 Assets $507,982,000 EPS -$0.28 Export Earnings Model
Allogene Therapeutics, Inc. (ALLO) 4/30/2025 6:02:09 AM   View Proxy SEC Y 2024
Allogene Therapeutics, Inc. (ALLO) 3/13/2025 4:13:25 PM Small View Financials 10-K SEC Y 2024 ending: 12/31/2024 Rev: $22,000 -76.8% Assets $548,710,000 EPS -$1.32
Allogene Therapeutics, Inc. (ALLO) 3/13/2025 4:04:41 PM   View Financials Earnings SEC Y 2024 Rev $0 Assets $548,710,000 EPS -$0.28 Export Earnings Model
Allogene Therapeutics, Inc. (ALLO) 11/7/2024 4:34:29 PM Small View Financials 10-Q SEC 3Q 2024 ending: 9/30/2024 Assets $589,120,000 EPS -$0.32
Allogene Therapeutics, Inc. (ALLO) 11/7/2024 4:07:51 PM   View Financials Earnings SEC 3Q 2024 Rev $0 Assets $589,120,000 EPS -$0.32 Export Earnings Model
Allogene Therapeutics, Inc. (ALLO) 8/7/2024 4:20:03 PM Small View Financials 10-Q SEC 2Q 2024 ending: 6/30/2024 Assets $646,883,000 EPS -$0.35
Allogene Therapeutics, Inc. (ALLO) 8/7/2024 4:07:32 PM   View Financials Earnings SEC 2Q 2024 Rev $0 Assets $646,883,000 EPS -$0.35 Export Earnings Model
Allogene Therapeutics, Inc. (ALLO) 5/13/2024 4:18:43 PM Small View Financials 10-Q SEC 1Q 2024 ending: 3/31/2024 Rev: $22,000 -26.7% Assets $586,350,000 EPS -$0.38
Allogene Therapeutics, Inc. (ALLO) 5/13/2024 4:03:16 PM   View Financials Earnings SEC 1Q 2024 Rev $22,000 -26.7% Assets $586,350,000 EPS -$0.38 Export Earnings Model
Allogene Therapeutics, Inc. (ALLO) 4/23/2024 4:37:29 PM   View Proxy SEC Y 2023
Allogene Therapeutics, Inc. (ALLO) 3/14/2024 5:09:19 PM Small View Financials 10-K SEC Y 2023 ending: 12/31/2023 Rev: $95,000 -39.1% Assets $642,837,000 EPS -$2.09
Allogene Therapeutics, Inc. (ALLO) 3/14/2024 4:18:51 PM Mid View Financials 10-K/A SEC Y 2022 ending: 12/31/2022 Rev: $156,000 -99.9% Assets $821,579,000 EPS -$2.38
Allogene Therapeutics, Inc. (ALLO) 3/14/2024 4:11:49 PM   View Financials Earnings SEC Y 2023 Rev $21,000 -19.2% Assets $642,837,000 EPS -$0.51 Export Earnings Model
Allogene Therapeutics, Inc. (ALLO) 11/2/2023 4:18:08 PM Small View Financials 10-Q SEC 3Q 2023 ending: 9/30/2023 Rev: $22,000 -18.5% Assets $713,411,000 EPS -$0.37
Allogene Therapeutics, Inc. (ALLO) 11/2/2023 4:04:42 PM   View Financials Earnings SEC 3Q 2023 Rev $22,000 -18.5% Assets $713,411,000 EPS -$0.37 Export Earnings Model
Allogene Therapeutics, Inc. (ALLO) 8/2/2023 4:20:32 PM Small View Financials 10-Q SEC 2Q 2023 ending: 6/30/2023 Rev: $22,000 -65.6% Assets $773,007,000 EPS -$0.54
Allogene Therapeutics, Inc. (ALLO) 8/2/2023 4:05:45 PM   View Financials Earnings SEC 2Q 2023 Rev $22,000 -65.6% Assets $773,007,000 EPS -$0.54 Export Earnings Model
Allogene Therapeutics, Inc. (ALLO) 5/3/2023 4:21:15 PM Small View Financials 10-Q SEC 1Q 2023 ending: 3/31/2023 Rev: $30,000 -23.1% Assets $750,128,000 EPS -$0.69
Allogene Therapeutics, Inc. (ALLO) 5/3/2023 4:06:18 PM   View Financials Earnings SEC 1Q 2023 Rev $30,000 -23.1% Assets $750,128,000 EPS -$0.69 Export Earnings Model
Allogene Therapeutics, Inc. (ALLO) 4/24/2023 4:09:59 PM   View Proxy SEC Y 2022
Allogene Therapeutics, Inc. (ALLO) 2/28/2023 4:31:06 PM Mid View Financials 10-K SEC Y 2022 ending: 12/31/2022 Rev: $156,000 -99.9% Assets $821,579,000 EPS -$2.38
Allogene Therapeutics, Inc. (ALLO) 2/28/2023 4:08:39 PM   View Financials Earnings SEC Y 2022 Rev $26,000 -100.0% Assets $821,579,000 EPS -$0.68 Export Earnings Model
Allogene Therapeutics, Inc. (ALLO) 11/2/2022 4:37:52 PM Mid View Financials 10-Q SEC 3Q 2022 ending: 9/30/2022 Rev: $27,000 -44.9% Assets $894,477,000 EPS -$0.59
Allogene Therapeutics, Inc. (ALLO) 11/2/2022 4:17:28 PM   View Financials Earnings SEC 3Q 2022 Rev $27,000 -44.9% Assets $894,477,000 EPS -$0.59 Export Earnings Model
Allogene Therapeutics, Inc. (ALLO) 8/11/2022 4:04:27 AM Mid View Financials 10-Q SEC 2Q 2022 ending: 6/30/2022 Rev: $64,000 +45.5% Assets $955,621,000 EPS -$0.56
Allogene Therapeutics, Inc. (ALLO) 8/9/2022 8:56:03 PM   View Financials Earnings SEC 2Q 2022 Rev $64,000 +45.5% Assets $955,621,000 EPS -$0.56 Export Earnings Model
Allogene Therapeutics, Inc. (ALLO) 5/4/2022 4:31:50 PM Mid View Financials 10-Q SEC 1Q 2022 ending: 3/31/2022 Rev: $39,000 -99.9% Assets $978,091,000 EPS -$0.56
Allogene Therapeutics, Inc. (ALLO) 5/4/2022 4:19:39 PM   View Financials Earnings SEC 1Q 2022 Rev $39,000 -99.9% Assets $978,091,000 EPS -$0.56 Export Earnings Model
Allogene Therapeutics, Inc. (ALLO) 4/26/2022 4:29:29 PM   View Proxy SEC Y 2021
Allogene Therapeutics, Inc. (ALLO) 2/23/2022 4:22:19 PM Mid View Financials 10-K SEC Y 2021 ending: 12/31/2021 Rev: $114,089,000 Assets $1,050,828,000 EPS -$1.34
Allogene Therapeutics, Inc. (ALLO) 2/23/2022 4:17:06 PM   View Financials Earnings SEC Y 2021 Rev $75,651,000 Assets $1,050,828,000 EPS $0.01 Export Earnings Model
Allogene Therapeutics, Inc. (ALLO) 11/4/2021 4:33:15 PM Mid View Financials 10-Q SEC 3Q 2021 ending: 9/30/2021 Rev: $49,000 Assets $1,079,246,000 EPS -$0.57
Allogene Therapeutics, Inc. (ALLO) 11/4/2021 4:32:43 PM   View Financials Earnings SEC 3Q 2021 Rev $49,000 Assets $1,079,246,000 EPS -$0.57 Export Earnings Model
Allogene Therapeutics, Inc. (ALLO) 8/4/2021 4:54:32 PM Mid View Financials 10-Q SEC 2Q 2021 ending: 6/30/2021 Rev: $44,000 Assets $1,126,724,000 EPS -$0.53
Allogene Therapeutics, Inc. (ALLO) 8/4/2021 4:39:51 PM   View Financials Earnings SEC 2Q 2021 Rev $44,000 Assets $1,126,724,000 EPS -$0.53 Export Earnings Model
Allogene Therapeutics, Inc. (ALLO) 5/5/2021 4:33:57 PM Mid View Financials 10-Q SEC 1Q 2021 ending: 3/31/2021 Rev: $38,345,000 Assets $1,179,044,000 EPS -$0.25
Allogene Therapeutics, Inc. (ALLO) 5/5/2021 4:23:24 PM   View Financials Earnings SEC 1Q 2021 Rev $38,345,000 Assets $1,179,044,000 EPS -$0.25 Export Earnings Model
Allogene Therapeutics, Inc. (ALLO) 4/22/2021 4:29:29 PM   View Proxy SEC Y 2020
Allogene Therapeutics, Inc. (ALLO) 2/25/2021 5:12:49 PM Mid View Financials 10-K SEC Y 2020 ending: 12/31/2020 Assets $1,227,829,000 EPS -$2.63
Allogene Therapeutics, Inc. (ALLO) 2/25/2021 4:12:14 PM   View Financials Earnings SEC Y 2020 Rev $0 Assets $1,227,829,000 EPS -$1.08 Export Earnings Model
Allogene Therapeutics, Inc. (ALLO) 11/4/2020 8:12:05 AM Mid View Financials 10-Q SEC 3Q 2020 ending: 9/30/2020 Assets $1,222,500,000 EPS -$0.52
Allogene Therapeutics, Inc. (ALLO) 11/4/2020 7:38:30 AM   View Financials Earnings SEC 3Q 2020 Rev $0 Assets $1,222,500,000 EPS -$0.52 Export Earnings Model
Allogene Therapeutics, Inc. (ALLO) 8/5/2020 7:54:19 AM Mid View Financials 10-Q SEC 2Q 2020 ending: 6/30/2020 Assets $1,258,544,000 EPS -$0.53
Allogene Therapeutics, Inc. (ALLO) 8/5/2020 7:37:29 AM   View Financials Earnings SEC 2Q 2020 Rev $0 Assets $1,258,544,000 EPS -$0.53 Export Earnings Model
Allogene Therapeutics, Inc. (ALLO) 5/6/2020 4:25:31 PM Small View Financials 10-Q SEC 1Q 2020 ending: 3/31/2020 Assets $688,523,000 EPS -$0.50
Allogene Therapeutics, Inc. (ALLO) 5/6/2020 7:37:31 AM   View Financials Earnings SEC 1Q 2020 Rev $0 Assets $688,523,000 EPS -$0.50 Export Earnings Model
Allogene Therapeutics, Inc. (ALLO) 4/23/2020 4:37:34 PM   View Proxy SEC Y 2019
Allogene Therapeutics, Inc. (ALLO) 2/27/2020 4:26:22 PM Small View Financials 10-K SEC Y 2019 ending: 12/31/2019 Assets $717,802,000 EPS -$1.83
Allogene Therapeutics, Inc. (ALLO) 2/27/2020 7:31:35 AM   View Financials Earnings SEC Y 2019 Rev $0 Assets $717,802,000 EPS -$0.59 Export Earnings Model
Allogene Therapeutics, Inc. (ALLO) 11/5/2019 4:26:40 PM Small View Financials 10-Q SEC 3Q 2019 ending: 9/30/2019 Assets $695,544,000 EPS -$0.50
Allogene Therapeutics, Inc. (ALLO) 11/5/2019 7:33:52 AM   View Financials Earnings SEC 3Q 2019 Assets $695,544,000 EPS -$0.50 Export Earnings Model
Allogene Therapeutics, Inc. (ALLO) 8/7/2019 4:35:55 PM Small View Financials 10-Q SEC 2Q 2019 ending: 6/30/2019 Assets $733,997,000 EPS -$0.41
Allogene Therapeutics, Inc. (ALLO) 8/7/2019 7:40:27 AM   View Financials Earnings SEC 2Q 2019 Assets $733,997,000 EPS -$0.41 Export Earnings Model
Allogene Therapeutics, Inc. (ALLO) 5/7/2019 4:36:01 PM Small View Financials 10-Q SEC 1Q 2019 ending: 3/31/2019 Assets $749,369,000 EPS -$0.32
Allogene Therapeutics, Inc. (ALLO) 5/7/2019 8:37:40 AM   View Financials Earnings SEC 1Q 2019 Assets $749,369,000 EPS -$0.32 Export Earnings Model
Allogene Therapeutics, Inc. (ALLO) 4/24/2019 8:03:19 AM   View Proxy SEC Y 2018
Allogene Therapeutics, Inc. (ALLO) 3/8/2019 4:25:43 PM Micro View Financials 10-K SEC Y 2018 ending: 12/31/2018
Allogene Therapeutics, Inc. (ALLO) 3/8/2019 8:11:24 AM   View Financials Earnings SEC Y 2018 Assets $773,855,000 EPS -$0.37 Export Earnings Model
Allogene Therapeutics, Inc. (ALLO) 11/21/2018 4:46:33 PM Micro View Financials 10-Q SEC 3Q 2018 ending: 9/30/2018